The 2019 Nobel Prize in Physiology or Medicine was awarded to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for their discovery of how cells sense and adapt to oxygen availability.

The research revealed that cells can sensitively detect oxygen levels in their surroundings. Under hypoxic (low oxygen) conditions, Hypoxia-Inducible Factor (HIF) accumulates inside cells and modulates the expression of more than 300 genes, switching cells to an alternative metabolic pattern to adapt to low-oxygen environments.

Chronic hypoxia is recognized as an important contributor to many diseases. Sustained oxygen deprivation disrupts normal cellular metabolism and increases risks of aging and related illnesses.

This discovery uncovered the fundamental molecular mechanism by which oxygen regulates cellular physiology. It greatly advances our understanding of hypoxia in human physiological and pathological processes and lays a theoretical foundation for oxygen metabolism research.

References

1. AAAS Science Article:https://www.science.org/content/article/medicine-nobel-honors-work-cellular-system-sense-oxygen-levels

2. Nobel Prize Official Press Release:https://www.nobelprize.org/prizes/medicine/2019/press-release/

3. Nobel Prize Advanced Scientific Background:https://www.nobelprize.org/prizes/medicine/2019/advanced-information/

DisclaimerThis article introduces the Nobel Prize-winning basic scientific discovery for educational reference only. This fundamental research describes cellular oxygen-sensing mechanisms. It does not constitute product efficacy claims and shall not be used to diagnose, treat or cure any disease.